Go to AAD Home
Donate For Public and Patients Store Search

Go to AAD Home
Welcome!
Advertisement
Advertisement

2026 quality measures for MIPS reporting


2026 QCDR measure specifications

Access a spreadsheet of 2026 QCDR measure specifications.

Access 2026 MIPS quality measures by selecting below.
MIPS 47

Advance Care Plan

MIPS 130

Documentation of Current Medications in the Medical Record

MIPS 176

Tuberculosis Screening Prior to First Course Biologic and/or Immune Response Modifier Therapy

MIPS 226

Tobacco Use: Screening and Cessation Intervention

MIPS 236

Controlling High Blood Pressure

MIPS 238

Use of High-Risk Medications in Older Adults 2026

MIPS 358

Patient-Centered Surgical Risk Assessment and Communication

MIPS 374

Closing the Referral Loop: Receipt of Specialist Report

MIPS 397

Melanoma Reporting

ïŧŋMIPS 410

Psoriasis: Clinical Response to Systemic Medications

MIPS 431

Unhealthy Alcohol Use: Screening & Brief Counseling

ïŧŋMIPS 440

Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician

ïŧŋMIPS 485

Psoriasis – Improvement in Patient-Reported Itch Severity

ïŧŋMIPS 486

Dermatitis – Improvement in Patient-Reported Itch Severity

MIPS 493

ïŧŋAdult Immunization Status

MIPS 503

Gains in Patient Activation Measure (PAM) Scores at 12 Months

ïŧŋMIPS 509

ïŧŋMelanoma: Tracking and Evaluation of Recurrence


Access 2026 QCDR measures by selecting below.
AAD 6

Skin Cancer: Biopsy Reporting Time – Clinician to Patient

AAD 8

Chronic Skin Conditions: Patient Reported Quality-of-Life

AAD 12

Melanoma: Appropriate Surgical Margins

AAD 15

ïŧŋPsoriasis – Appropriate Assessment & Treatment of Severe Psoriasis

AAD 16

Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures

AAD 20

Actinic Keratosis: Patient-reported Treatment Effectiveness and Care Satisfaction

AAD 21

Actinic Keratosis: Appropriate Documentation and Shared Decision Making of AK

Advertisement
Advertisement
Advertisement